Global Access Program - Cervical Cancer

Making high-risk HPV screening available to women in greatest need

Roche is committed to eradicate cervical cancer globally

increasing screening accuracy, efficiency and access for all women

Addressing unmet global need

Cervical cancer is a preventable disease, but is one of the most common cancers in women.
Cervical cancer is one of the greatest threats to women's health. Every minute, one woman is diagnosed with cervical cancer. Each year, more than 300 000 women die of cervical cancer. We can do more to address this problem.

Estimated age-standardized incidence rates (World) in 2018, cervix uteri, females, all ages

Estimated age-standardized incidence rates (World) in 2018

Majority of disease burden is in Low & Middle Income Countries (LMIC)

“Nine out of 10 women who die from cervical cancer live in low- and middle-income countries.”

"Women living with HIV are four to five times more likely to develop invasive cervical cancer. HPV infection has been found to significantly increase the risk  of HIV transmission for both man and women."

Some of the most vulnerable women in our world are dying unnecessarily. In poorer countries, women are often diagnosed with cervical cancer at a more advanced stage, where the opportunity for a cure is low. This is compounded by a lack of access to life-saving treatment in settings where the burden and need is highest.

There is a global call for action to meet proposed cervical cancer prevention goals by 2030.


"Every country must introduce and scale-up HPV

screening for women between 30 and 49 years old,

and ensure appropriate treatment and follow-up.1"


Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, 24 September 2018

"Elimination of cervical cancer as a global health

problem is within reach for all countries. We

know what works, and we now need to scale up

our actions to prevent and control this disease."


Dr Princess Nono Simelela, Assistant Director-General for Family, Women,
Children and Adolescents, WHO

Prevention Opportunity


A combination of vaccination and HPV-based screening programs can prevent cervical cancer.
Prevention opportunity Flowchart


- Modern HPV DNA testing identifies the cause of >99% of cervical cancer 2
- Women identified to be at-risk can be monitored for early treatment when needed



  1. (accessed 6/2018)
  2. Walboomers, J.M., et al. 1999;189(1):12-9..